This is a federal contract award to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract, with a ceiling value of $21,035.74, is a delivery order under Merck's General Services Administration (GSA) Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. The contract is for the drug SOTATERCEPT, with a performance period ending on January 10, 2025. The contracting agency is the Veterans Integrated Service Network 10 (VISN 10), a civilian agency within the U.S. Department of Veterans Affairs. The contract does not have a set-aside designation. Merck has extensive experience providing a wide range of vaccines, drugs, and medical countermeasures to support various federal healthcare programs and initiatives, including those at the Department of Veterans Affairs, Department of Defense, Department of Health and Human Services, and the Centers for Disease Control and Prevention.
Generated 12/12/24, 10:49 AM